Redox Limited (ASX:RDX)
Australia · Delayed Price · Currency is AUD | Market Cap | 1.81B +20.7% |
| Revenue (ttm) | 1.33B +6.9% |
| Net Income | 91.91M +19.2% |
| EPS | 0.17 +19.2% |
| Shares Out | 525.08M |
| PE Ratio | 19.91 |
| Forward PE | 18.73 |
| Dividend | 0.13 (3.78%) |
| Ex-Dividend Date | Aug 25, 2026 |
| Volume | 642,024 |
| Open | 3.440 |
| Previous Close | 3.480 |
| Day's Range | 3.370 - 3.450 |
| 52-Week Range | 2.500 - 4.160 |
| Beta | -0.45 |
| Analysts | Buy |
| Price Target | 3.99 (+15.99%) |
| Earnings Date | Aug 20, 2026 |
About Redox
Redox Limited supplies and distributes chemicals, ingredients, and raw materials in Australia, New Zealand, Malaysia, and the United States. It offers antioxidants, proteins and fibres, leaving agents, acidity regulator, sweeteners, thickeners, stabilizers and gums, vitamins, amino acids, mineral salts, preservatives, phosphates, humectants, essential and vegetable oils, herb and spice extracts, natural colours, emulsifier, dairy products, wine and brewing, cleaning and sanitation, specialities, additives, chemicals, emollients, emulsifiers, ha... [Read more]
Financial Performance
In fiscal year 2026, Redox's revenue was 1.33 billion, an increase of 6.95% compared to the previous year's 1.24 billion. Earnings were 91.91 million, an increase of 19.21%.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for RDX stock is "Buy." The 12-month stock price target is $3.99, which is an increase of 15.99% from the latest price.
News
Redox Transcript: AGM 2026
FY 2026 revenue reached AUD 1.33bn and EPS rose 20%; dividends increased 4% to AUD 0.13 per share. FY 2027 priorities include growth, acquisitions, cost control and selective AI adoption, amid inflation and freight pressures.
Redox Slides: FY 2026
Redox has posted slides in relation to its FY 2026 quarterly earnings report, which was published on October 6, 2026.
Redox Earnings Call Transcript: H2 2026
Revenue grew 6.9% to AUD 1.33 billion, with strong organic and North American growth. Gross profit margin improved to 22.4%, and NPAT rose 19.2%. Outlook for FY 2027 includes further price inflation and continued volume growth, with North America as the expansion focus.
Redox Earnings release: H2 2026
Redox released its H2 2026 earnings on August 19, 2026, summarizing the period's financial results.
Redox Slides: H2 2026
Redox has posted slides in relation to its H2 2026 quarterly earnings report, which was published on August 19, 2026.
Redox Annual report: H2 2026
Redox has published its H2 2026 annual report on August 19, 2026.
Redox Earnings Call Transcript: H1 2026
Sales grew 6.6% to AUD 674 million, with strong industrial and food segment gains and robust North American performance. Gross profit and EPS rose, supported by disciplined costs and a strong net cash position, while management anticipates upward pricing pressure and continued M&A activity.
Redox Quarterly report: H1 2026
Redox has published its H1 2026 quarterly earnings report on February 18, 2026.
Redox Slides: H1 2026
Redox has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 18, 2026.
Redox Earnings release: H1 2026
Redox released its H1 2026 earnings on February 18, 2026, summarizing the period's financial results.